Status:
COMPLETED
Evaluation of Adult Patients With Immunodeficiency Within the Scope of the ICF
Lead Sponsor:
Hacettepe University
Collaborating Sponsors:
Baskent University
Conditions:
Primary Immune Deficiency
Exercise Capacity
Eligibility:
All Genders
18-65 years
Brief Summary
Primary immunodeficiency is a clinically, immunologically, and genetically heterogeneous group of diseases that occur as a result of quantitative and/or qualitative deficiency of one or more cellular ...
Detailed Description
Primary immunodeficiency is a clinically, immunologically and genetically heterogeneous group of diseases that occur as a result of quantitative and/or qualitative deficiency of one or more cellular a...
Eligibility Criteria
Inclusion
- Criteria for Inclusion in the Adult Immunodeficiency Group
- to be between the ages of 18-65 years old.
- to be volunteer to participate in research
- to have been diagnosed with Primary Immunodeficiency
- to be taking immunoglobulin replacement therapy
- to have no problems in reading and/or understanding scales and being able to cooperate with tests
- Criteria for exclusion of the Adult Immunodeficiency Group:
- The presence of active infection
- Musculoskeletal and neurological disease that may affect exercise performance symptomatic heart disease
- To have a neurological disease or other clinical diagnosis that may affect cognitive status
- Criteria for inclusion in the control group:
- to be between the ages of 18-65 years old
- to give informed consent
- to have no problems in reading and/or understanding scales and being able to cooperate with tests
- Criteria for exclusion of the Control Group:
- to have any orthopedic or neuromuscular disorder that will interfere with walking or exercise performance,
- to have any chronic disease or to have psychiatric disorders or mental influences that may prevent cooperation or compliance with exercise tests.
Exclusion
Key Trial Info
Start Date :
March 15 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 15 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06014463
Start Date
March 15 2023
End Date
January 15 2024
Last Update
February 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ebru Çalık Kutukcu
Ankara, Hacettepe Unıversity, Turkey (Türkiye), 06100